Risk Factors and Outcome of Biliary Complications Following Adult Living Donor Liver Transplantation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03789383|
Recruitment Status : Not yet recruiting
First Posted : December 28, 2018
Last Update Posted : July 3, 2019
Liver transplantation (LT) is a live-saving therapy for patients with complicated chronic liver diseases and acute liver failure .Even though many complications can occur after LT, biliary complications (BC) are both common and potentially severe .
a prospective study and retrospective part from hospital records.
Aim of the study:
- Detect frequency, risk factors for development of biliary complications post living donor liver transplantation, types (stricture anastomotic or not, leak, biloma, stone, cholangitis etc.…).
- Evaluate outcomes of different biliary complications
|Condition or disease|
|Liver Transplant; Complications|
|Study Type :||Observational|
|Estimated Enrollment :||50 participants|
|Official Title:||Risk Factors and Outcome of Biliary Complications Following Adult Living Donor Liver Transplantation in Al-Rajhy Liver Hospital in Upper Egypt.|
|Estimated Study Start Date :||January 1, 2020|
|Estimated Primary Completion Date :||December 30, 2021|
|Estimated Study Completion Date :||February 1, 2022|
- Incidence of biliary complications [ Time Frame: 1 year after liver transplantation ]Biliary complications include biliary leak or stricture (anastomotic or non anastomotic), the investigator will record nature of complication , its time of presentation and number of hospital re-admissions due to biliary complications.
- Type of intervention done to each complication [ Time Frame: 1 year after liver transplantation ]Intervention is either non surgical (ERCP or PTD) or surgical revision with detailed description of each intervention and if the intervention is successful or not (biliary stricture resolved by MRCP, improvement of liver functions and symptoms)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03789383
|Contact: Sara Sedeekfirstname.lastname@example.org|
|Al-Rajhy liver hospital||Not yet recruiting|
|Contact: Sara Sedeek email@example.com|
|Principal Investigator: Madiha El-attar|
|Principal Investigator: Mohamed Abd-elmalek|
|Principal Investigator: Sara Sedeek|